Hope And Hype For New Type Of Antidepressant
Two brothers - one an entrepreneur, the other a Columbia University psychiatrist - are claiming today that a new combination of experimental medicines may prevent suicidal thoughts in people with bipolar disorder.
The drug, D-cycloserine, was originally developed as a treatment for tuberculosis. Now, the brothers, Jonathan (CEO) and Daniel (scientist) Javitt, have founded a new company, NeuroRx, to develop it as an antidepressant. "Certainly neither one of us will say this is anything other than a very initial open-label study that is very preliminary," says Daniel. Read more here.
|